Literature DB >> 18406905

Quality assurance challenges for motion-adaptive radiation therapy: gating, breath holding, and four-dimensional computed tomography.

Steve B Jiang1, John Wolfgang, Gig S Mageras.   

Abstract

Compared with conventional three-dimensional (3D) conformal radiation therapy and intensity-modulated radiation therapy treatments, quality assurance (QA) for motion-adaptive radiation therapy involves various challenges because of the added temporal dimension. Here we discuss those challenges for three specific techniques related to motion-adaptive therapy: namely respiratory gating, breath holding, and four-dimensional computed tomography. Similar to the introduction of any other new technologies in clinical practice, typical QA measures should be taken for these techniques also, including initial testing of equipment and clinical procedures, as well as frequent QA examinations during the early stage of implementation. Here, rather than covering every QA aspect in depth, we focus on some major QA challenges. The biggest QA challenge for gating and breath holding is how to ensure treatment accuracy when internal target position is predicted using external surrogates. Recommended QA measures for each component of treatment, including simulation, planning, patient positioning, and treatment delivery and verification, are discussed. For four-dimensional computed tomography, some major QA challenges have also been discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18406905     DOI: 10.1016/j.ijrobp.2007.07.2386

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

Review 1.  Cardiac toxicity of lung cancer radiotherapy.

Authors:  Radovan Vojtíšek
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-14

2.  Quality and accuracy of cone beam computed tomography gated by active breathing control.

Authors:  Bria P Thompson; Geoffrey D Hugo
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

3.  Investigation into the feasibility of using PRESAGE/optical-CT dosimetry for the verification of gating treatments.

Authors:  Samuel L Brady; William E Brown; Corey G Clift; Sua Yoo; Mark Oldham
Journal:  Phys Med Biol       Date:  2010-03-26       Impact factor: 3.609

4.  Fast parallel algorithms for the x-ray transform and its adjoint.

Authors:  Hao Gao
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

5.  A survey of stereotactic body radiotherapy use in the United States.

Authors:  Hubert Pan; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

6.  Robust principal component analysis-based four-dimensional computed tomography.

Authors:  Hao Gao; Jian-Feng Cai; Zuowei Shen; Hongkai Zhao
Journal:  Phys Med Biol       Date:  2011-05-04       Impact factor: 3.609

7.  Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis.

Authors:  Hubert Pan; Brent S Rose; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

8.  Investigation of gated cone-beam CT to reduce respiratory motion blurring.

Authors:  Russell E Kincaid; Ellen D Yorke; Karyn A Goodman; Andreas Rimner; Abraham J Wu; Gig S Mageras
Journal:  Med Phys       Date:  2013-04       Impact factor: 4.071

9.  Evaluation of tumor localization in respiration motion-corrected cone-beam CT: prospective study in lung.

Authors:  Oleksandr Dzyubak; Russell Kincaid; Agung Hertanto; Yu-Chi Hu; Hai Pham; Andreas Rimner; Ellen Yorke; Qinghui Zhang; Gig S Mageras
Journal:  Med Phys       Date:  2014-10       Impact factor: 4.071

10.  Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.

Authors:  Tetsuya Inoue; Norio Katoh; Rikiya Onimaru; Shinichi Shimizu; Kazuhiko Tsuchiya; Ryusuke Suzuki; Jun Sakakibara-Konishi; Naofumi Shinagawa; Satoshi Oizumi; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2013-03-21       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.